Scientists probe immune secrets of chronic hepatitis b
NCT ID NCT01298037
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the immune system behaves in people with chronic hepatitis B. Researchers are measuring different immune cells and signals to understand why some people control the virus better than others. 201 adults already enrolled in a larger hepatitis B study are providing blood samples for this analysis. No new treatments are being tested; the goal is to learn more about the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115, United States
-
California Pacific Medical Center
San Francisco, California, 94107, United States
-
Harborview Medical Center
Seattle, Washington, 98104, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
University of California San Francisco Medical Center
San Francisco, California, 94143, United States
-
University of Minnesota
Plymouth, Minnesota, 55446, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
-
University of Texas Southwestern
Dallas, Texas, 75390, United States
-
University of Toronto
Toronto, Ontario, ON M5G 1X8, Canada
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
-
Virginia Mason Medical Center
Seattle, Washington, 98101, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple roadside test catch liver disease before it turns deadly?
- Hospital care model aims to treat opioid addiction and serious infections together
- Simple blood test aims to spot multiple cancers early
- Heart safety check for hepatitis b drug candidate
- Two-Drug combo aims to cure chronic hepatitis b
- Hepatitis b breakthrough? study checks if bepirovirsen response lasts